The Hemophilia Treatment Market Volume is on an upward trajectory, poised to escalate from USD 12.4 billion in 2024 to USD 19.6 billion by 2035, reflecting a CAGR of 4.25%. This growth is supported by an increase in the prevalence of hemophilia and the rapid development of innovative treatment options. Enhanced awareness around the condition is also driving greater demand for therapies among...